开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2024-09-11 ms4000001640011867 来自福建省

偏重的研究方向：肿瘤;药学
经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。

3 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2024-05-21 biocell160 来自贵州省

不是很快嘛，pending review一般多久啊

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2024-07-21 ms5000000105524119 来自广西

😭第一作者是医院的被模版拒了

50 0

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2024-07-05 ms5000000105524119 来自广西

偏重的研究方向：药学
经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛

51 0

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2024-04-23 ms4000000323459199 来自江苏省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：不难

60 0

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2021-09-14 1de65763m65(暂无匿称)

审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0
偏重的研究方向：miRNAs;cancer;Bioinformatics
经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费

133 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2023-03-02 ms7000002142912750 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：医学
经验分享：很快接受

89 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2023-11-04 ms3000000019971711 来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：脑
经验分享：mjjk

82 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2023-12-10 ms5000001127810224 来自浙江省

审稿速度:1.0
经验分享：pending review已经10天了

84 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225227, encodeId=1e18222522e22, content=偏重的研究方向：肿瘤;药学 经验分享：发邮件来特刊征稿，拒的概率大吗？单位是医院。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Wed Sep 11 15:28:59 CST 2024, time=2024-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2205815, encodeId=93fc22058154d, content=不是很快嘛，pending review一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Tue May 21 12:46:39 CST 2024, time=2024-05-21, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2216113, encodeId=a2f622161133f, content=😭第一作者是医院的被模版拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Sun Jul 21 18:41:29 CST 2024, time=2024-07-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2213356, encodeId=6baf2213356f4, content=偏重的研究方向：药学 经验分享：请问拒稿率高嘛？需要提供Wb原始条带和其他原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63938764578, createdName=ms5000000105524119, createdTime=Fri Jul 05 02:10:34 CST 2024, time=2024-07-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2200002, encodeId=73c42200002a6, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0589221513, createdName=ms4000000323459199, createdTime=Tue Apr 23 19:00:39 CST 2024, time=2024-04-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0 偏重的研究方向：miRNAs;cancer;Bioinformatics 经验分享：初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脑 经验分享：mjjk , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0 经验分享：pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=2024-03-04, status=1, ipAttribution=上海)]

2024-03-04 ms9000000402523044 来自上海

试试看

81 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务